Fulgent Genetics has received Emergency Use Authorization from the FDA to provide at-home testing services for SARS-CoV-2, the virus that causes COVID-19 TEMPLE CITY, Calif., June 16, 2020 (GLOBE ...

Earlier this week, Fulgent announced an agreement to acquire independent pathology laboratory Inform Diagnostics for approximately $170 million in cash. One of the benefits of the influx of ...

Fulgent used its genetics test platform to launch at-home Covid tests. Just two years ago, Temple City-based Fulgent Genetics Inc. was a small but promising genetic testing company with $32 million in ...

Fulgent’s arsenal has expanded to include a monkeypox test. Just as its record testing run for Covid-19 appears to be tapering off, Temple City-based Fulgent Genetics Inc. has added testing for ...

Fulgent Genetics will partner with MedScan Laboratory to launch one of the market’s first COVID-19 tests based on comprehensive Next Generation Sequencing technology TEMPLE CITY, Calif., March 17, ...

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a ...

In the most recent quarter, Fulgent's revenue grew to $126 million, a 124% increase over the third quarter of 2020. Taking a look at previous quarters, the overall revenue results for the company have ...

Northwestern announced its new, free testing program August 19, which will begin with a three-step process for all undergraduate students returning to campus. The first part involves an at-home test ...

Fulgent Genetics is launching an at-home testing solution for the coronavirus. The Temple City, CA-based company received emergency use authorization from FDA for the diagnostic, which tests for ...

Fulgent Genetics FLGT shares spiked nearly 10% in the after-hours session Wednesday, as the company said it would supply COVID-19 testing to hundreds of thousands of students in partnership with New ...

Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base EL MONTE, Calif., December 22, 2025--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: ...

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent”, or the “Company”), a technology-based genetic ...